GlassScriptPhysician profile
Thomas Riddell
NPI 1043454895
$9,771.75
in general payments reported to CMS, 2019-2025
26 companies · $4,493 in 2025
The $4,493 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $562 · 2021: $639 · 2022: $536 · 2023: $856 · 2024: $1,132 · 2025: $4,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,171 · Travel and Lodging: $2,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,171.17 |
| Travel and Lodging | $2,309.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,104.72 | 2022-2025 | Indigo System, Penumbra System |
| Edwards Lifesciences Corporation | $1,142.14 | 2019-2020 | |
| Medtronic, INC. | $1,048.24 | 2021-2025 | Venaseal, Onyx Frontier, Closurefast |
| Boston Scientific Corporation | $535.32 | 2019-2025 | Rhythmia Mapping System, Varithena Administration Pack, Watchman Access System |
| Medtronic Vascular, INC. | $409.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $360.30 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $311.33 | 2021-2024 | Xarelto |
| Abbott Laboratories | $302.11 | 2019-2025 | Diamondback Coronary, Xience Skypoint, Mini Trek |
| Inspire Medical Systems, INC. | $265.33 | 2023-2025 | Inspire |
| Pfizer INC. | $246.41 | 2020-2024 | |
| Philips North America LLC | $218.85 | 2023-2025 | IV Other |
| Cardiovascular Systems INC. | $151.43 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $116.84 | 2025 | Camzyos |
| Amgen INC. | $91.94 | 2022-2025 | Repatha, Repatha |
| Abiomed | $89.48 | 2019-2024 | Impella |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $82.14 | 2021-2024 | |
| Biocompatibles, INC. | $63.17 | 2019 | |
| Inari Medical, INC. | $49.91 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biosense Webster, INC. | $36.68 | 2025 | Carto 3 |
| Teleflex LLC | $30.66 | 2025 | Orsiro Mission |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $25.70 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $19.16 | 2024 | Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $14.88 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $14.17 | 2023 | |
| Zoll Circulation INC | $11.38 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Riddell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.